Certified by Founder Lodge
Dreavent
United States - Cambridge, Massachusetts
INVESTOR
1 Disclosed Funding Rounds $6,000,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Dreavent is an investment firm focused on Biotech Therapeutics companies. Our strategic location in the preeminent biotech hub, combined with a worldwide network of investors and partners, al
| Company | Date | Round | Raised |
|---|---|---|---|
 Astrocyte Pharmaceuticals |
August, 22 ,2023 | Pre-Series B | $6,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Transaera, Inc. | $10,500,000 | (Nov 5, 2024)
Algebrik AI | $4,000,000 | (Nov 5, 2024)
Insider. | $500,000,000 | (Nov 5, 2024)
Cintoo | $40,246,701 | (Nov 5, 2024)
Advex AI | $3,500,000 | (Nov 5, 2024)
![[cafeteria]](/uploads/YMFDSSydz53lMbT1730171990.png)
